Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.

BACKGROUND Cerebrospinal fluid (CSF) and neuroimaging abnormalities demonstrate neuronal injury during chronic AIDS, but data on these biomarkers during primary human immunodeficiency virus (HIV) infection is limited. METHODS We compared CSF concentrations of neurofilament light chain, t-tau, p-tau, amyloid precursor proteins, and amyloid-beta 42 in 92 subjects with primary HIV infection and 25 controls. We examined relationships with disease progression and neuroinflammation, neuropsychological testing, and proton-magnetic resonance spectroscopy (MRS)-based metabolites. RESULTS Neurofilament light chain was elevated in primary HIV infection compared with controls (P = .0004) and correlated with CSF neopterin (r = 0.38; P = .0005), interferon gamma-induced protein 10 (r = 0.39; P = .002), white blood cells (r = 0.32; P = .004), protein (r = 0.59; P < .0001), and CSF/plasma albumin ratio (r = 0.60; P < .0001). Neurofilament light chain correlated with decreased N-acteylaspartate/creatine and glutamate/creatine in the anterior cingulate (r = -0.35, P = .02; r = -0.40, P = .009, respectively), frontal white matter (r = -0.43, P = .003; r = -0.30, P = .048, respectively), and parietal gray matter (r = -0.43, P = .003; r = -0.47, P = .001, respectively). Beta-amyloid was elevated in the primary infection group (P = .0005) and correlated with time infected (r = 0.34; P = .003). Neither marker correlated with neuropsychological abnormalities. T-tau and soluble amyloid precursor proteins did not differ between groups. CONCLUSIONS Elevated neurofilament light chain and its correlation with MRS-based metabolites suggest early neuronal injury in a subset of participants with primary HIV infection through mechanisms involving central nervous system inflammation.

[1]  K. Blennow,et al.  Open‐heart surgery increases cerebrospinal fluid levels of Alzheimer‐associated amyloid β , 2013, Acta anaesthesiologica Scandinavica.

[2]  D. Meyerhoff,et al.  Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. , 2012, Drug and alcohol dependence.

[3]  Jintanat Ananworanich,et al.  Central nervous system viral invasion and inflammation during acute HIV infection. , 2012, The Journal of infectious diseases.

[4]  D. Fuchs,et al.  Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. , 2011, The Journal of infectious diseases.

[5]  E. Halpern,et al.  Brain creatine elevation and N‐acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of NeuroAIDS , 2011, Magnetic resonance in medicine.

[6]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[7]  Terry L. Jernigan,et al.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors , 2010, Journal of NeuroVirology.

[8]  Linda Chang,et al.  Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV‐associated neurocognitive disorder , 2010, Journal of magnetic resonance imaging : JMRI.

[9]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[10]  K. Blennow,et al.  Amyloid and tau cerebrospinal fluid biomarkers in HIV infection , 2009, BMC neurology.

[11]  A. Fagan,et al.  CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease , 2009, Neurology.

[12]  E. Halpern,et al.  In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain , 2009, BMC Neuroscience.

[13]  J T Becker,et al.  Biomarkers of HIV-1 CNS infection and injury , 2007, Neurology.

[14]  R. Price,et al.  Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection , 2007, Neurology.

[15]  R. Price,et al.  Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. , 2007, The Journal of infectious diseases.

[16]  R. Price,et al.  CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegeneration , 2007, Journal of Neurology.

[17]  I. Grant,et al.  The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence , 2007, Journal of clinical and experimental neuropsychology.

[18]  C. Pilcher,et al.  Diagnosis and management of acute HIV infection. , 2007, Infectious disease clinics of North America.

[19]  K. Blennow,et al.  Neurochemical aftermath of amateur boxing , 2006, Archives of neurology.

[20]  R. Gonzalez,et al.  New Insights into the Neuroimmunity of SIV Infection by Magnetic Resonance Spectroscopy , 2006, Journal of Neuroimmune Pharmacology.

[21]  K. Blennow,et al.  CSF amyloid β42 and tau levels correlate with AIDS dementia complex , 2005, Neurology.

[22]  C. Petropoulos,et al.  Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment , 2005, BMC infectious diseases.

[23]  R. Price,et al.  Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection , 2005, AIDS research and therapy.

[24]  E. Halpern,et al.  Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. , 2005, Radiology.

[25]  Hilkka Soininen,et al.  CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment , 2005, Neurology.

[26]  E. Masliah,et al.  Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients , 2005, AIDS.

[27]  N. Norgren,et al.  Neurofilament and glial fibrillary acidic protein in multiple sclerosis , 2004, Neurology.

[28]  Linda Chang,et al.  Regional patterns of brain metabolites in AIDS dementia complex , 2004, NeuroImage.

[29]  N. Norgren,et al.  Elevated neurofilament levels in neurological diseases , 2003, Brain Research.

[30]  H. Vanderstichele,et al.  Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias , 2003, Molecular Psychiatry.

[31]  W. Miller,et al.  HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health , 2001, AIDS.

[32]  K. Blennow,et al.  Both total and phosphorylated tau are increased in Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[33]  M. Grassi,et al.  Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients , 2001, AIDS.

[34]  V. Calvez,et al.  Clinical and spectroscopic improvement in HIV-associated cognitive impairment , 2001, Neurology.

[35]  L. Papagno,et al.  Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  D. Fuchs,et al.  Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients , 2000, Journal of Neuroimmunology.

[37]  K. Blennow,et al.  Increased cerebrospinal fluid protein tau concentration in neuro-AIDS , 1999, Journal of the Neurological Sciences.

[38]  V. Govindaraju,et al.  Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.

[39]  D. Galasko,et al.  Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans , 1998, Neuroscience Letters.

[40]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[41]  Michael J. Taylor,et al.  The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.

[42]  G. Fein,et al.  Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.

[43]  K. Blennow,et al.  CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. , 2005, Neurology.

[44]  H. Soininen,et al.  CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. , 2005, Neurology.